DE69735684D1 - Katalytische Nukleinsäure und deren medizinische Verwendung - Google Patents

Katalytische Nukleinsäure und deren medizinische Verwendung

Info

Publication number
DE69735684D1
DE69735684D1 DE69735684T DE69735684T DE69735684D1 DE 69735684 D1 DE69735684 D1 DE 69735684D1 DE 69735684 T DE69735684 T DE 69735684T DE 69735684 T DE69735684 T DE 69735684T DE 69735684 D1 DE69735684 D1 DE 69735684D1
Authority
DE
Germany
Prior art keywords
nucleic acid
molecules
medical use
catalytic nucleic
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69735684T
Other languages
English (en)
Other versions
DE69735684T2 (de
Inventor
Nathan Givat Sharett Asher
Andy Ellington
Yaron Tikochinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENETICO Ltd
Original Assignee
GENETICO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL119135A external-priority patent/IL119135A/en
Priority claimed from IL12046697A external-priority patent/IL120466A0/xx
Application filed by GENETICO Ltd filed Critical GENETICO Ltd
Publication of DE69735684D1 publication Critical patent/DE69735684D1/de
Application granted granted Critical
Publication of DE69735684T2 publication Critical patent/DE69735684T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/124—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes based on group I or II introns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/337—Ribozyme

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69735684T 1996-08-26 1997-08-26 Katalytische Nukleinsäure und deren medizinische Verwendung Expired - Fee Related DE69735684T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL11913596 1996-08-26
IL119135A IL119135A (en) 1996-08-26 1996-08-26 Catalytic nucleic acid molecules
IL12046697 1997-03-17
IL12046697A IL120466A0 (en) 1997-03-17 1997-03-17 In vitro evolution of oligonucleotides

Publications (2)

Publication Number Publication Date
DE69735684D1 true DE69735684D1 (de) 2006-05-24
DE69735684T2 DE69735684T2 (de) 2007-04-05

Family

ID=26323298

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69725861T Expired - Fee Related DE69725861T2 (de) 1996-08-26 1997-08-26 Katalytische nukleinsäuren und deren medizinische verwendung
DE69735684T Expired - Fee Related DE69735684T2 (de) 1996-08-26 1997-08-26 Katalytische Nukleinsäure und deren medizinische Verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69725861T Expired - Fee Related DE69725861T2 (de) 1996-08-26 1997-08-26 Katalytische nukleinsäuren und deren medizinische verwendung

Country Status (11)

Country Link
US (1) US6387617B1 (de)
EP (2) EP1350854B1 (de)
JP (1) JP2000517181A (de)
CN (1) CN1232509A (de)
AT (2) ATE323180T1 (de)
AU (1) AU717736B2 (de)
CA (1) CA2264246A1 (de)
DE (2) DE69725861T2 (de)
NO (1) NO990850L (de)
NZ (1) NZ334492A (de)
WO (1) WO1998008974A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724627B2 (en) 1996-12-19 2000-09-28 Yale University Bioreactive allosteric polynucleotides
IL120714A0 (en) * 1997-04-21 1997-08-14 Intelligene Ltd Continuous in vitro evolution of oligonucleotides
EP1019429A4 (de) * 1997-08-20 2001-08-08 Somagenics Inc Antisense- und antigen-therapeutika mit verbesserten bindungseigenschaften und methoden zu ihrer anwendung
IL126732A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd Pro drug
IL126731A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd A method of detection
WO2000024912A1 (en) * 1998-10-23 2000-05-04 The Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression
IL130606A0 (en) * 1999-06-23 2000-06-01 Intelligene Ltd An array of nucleic acid sequence
US6506887B1 (en) 1999-07-29 2003-01-14 Somalogic, Incorporated Conditional-selex
IL132710A0 (en) * 1999-11-02 2001-03-19 Intelligene Ltd Catalytic nucleic acid sequences
EP1290154A2 (de) * 2000-03-01 2003-03-12 Amgen Inc. Identifizierung und verwendung von effektoren und allosterischen molekülen zur änderung der genexpression
JP2004515219A (ja) * 2000-06-15 2004-05-27 ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 調節可能な触媒活性な核酸
AU2001266917A1 (en) * 2000-06-15 2001-12-24 Board Of Regents Allosterically regulated ribozymes
US6706474B1 (en) * 2000-06-27 2004-03-16 Board Of Trustees Of The University Of Illinois Nucleic acid enzyme biosensors for ions
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
US20030219422A1 (en) * 2001-11-15 2003-11-27 Noxxon Pharma Ag Allosteric ribozymes and uses thereof
US6890719B2 (en) 2002-05-10 2005-05-10 The Board Of Trustess Of The University Of Illinois Fluorescence based biosensor
EP1543158B1 (de) 2002-07-25 2011-07-13 Archemix Corp. Regulierte aptamer-therapeutika
US8039443B2 (en) 2002-11-21 2011-10-18 Archemix Corporation Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US10100316B2 (en) 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
WO2004055198A2 (en) * 2002-12-12 2004-07-01 Chiron Corporation Device and method for in-line blood testing using biochips
US7892734B2 (en) * 2005-08-11 2011-02-22 The Board Of Trustees Of The University Of Illinois Aptamer based colorimetric sensor systems
WO2007109500A1 (en) * 2006-03-16 2007-09-27 The Board Of Trustees Of The University Of Illinois Lateral flow devices
US8415461B2 (en) * 2007-01-19 2013-04-09 The Board Of Trustees Of The University Of Illinois Amphiphilic substances and functionalized lipid vesicles including the same
US20080207885A1 (en) * 2007-02-23 2008-08-28 Silverman Scott K Method for site-specific labeling of RNA using a deoxyribozyme
US8058415B2 (en) * 2007-04-24 2011-11-15 The Board Of Trustees Of The University Of Illinois Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
WO2009012309A2 (en) * 2007-07-16 2009-01-22 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for divalent copper ion detection
US8568690B2 (en) * 2007-07-31 2013-10-29 The Board Of Trustees Of The University Of Illinois MRI contrast agents and high-throughput screening by MRI
WO2009045632A2 (en) 2007-08-10 2009-04-09 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for mercury detection
US20100105039A1 (en) * 2008-06-03 2010-04-29 Yi Lu Label-free colorimetric detection
US8062893B2 (en) 2008-10-10 2011-11-22 The Board Of Trustees Of The University Of Illinois Fluorescent sensor for mercury
US20100305197A1 (en) * 2009-02-05 2010-12-02 Massachusetts Institute Of Technology Conditionally Active Ribozymes And Uses Thereof
US8815156B2 (en) 2010-07-19 2014-08-26 Andalyze, Inc. Sensor housing and reagent chemistry
EP2780456A1 (de) * 2011-11-17 2014-09-24 The U.S.A. as represented by the Secretary, Department of Health and Human Services Therapeutische rna schalter-zusammensetzungen und anwendungsverfahren dafür

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3276955B2 (ja) 1988-09-30 2002-04-22 ジーン−トラック・システムス Ｒｎａの鋳型の末端に結合したプローブ構造およびその使用方法
WO1994013791A1 (en) 1992-12-04 1994-06-23 Innovir Laboratories, Inc. Regulatable nucleic acid therapeutic and methods of use thereof
ATE217347T1 (de) * 1992-12-04 2002-05-15 Univ Yale Diagnose mittels signalverstärkung durch ein ribozym
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
WO1996023569A1 (fr) 1995-02-03 1996-08-08 Nippondenso Co., Ltd. Filtre
MX9706501A (es) * 1995-02-27 1998-02-28 Intelligene Ltd Deteccion de biomoleculas.

Also Published As

Publication number Publication date
DE69725861T2 (de) 2004-08-19
NO990850L (no) 1999-04-23
NO990850D0 (no) 1999-02-23
EP1350854B1 (de) 2006-04-12
WO1998008974A3 (en) 1998-07-02
US6387617B1 (en) 2002-05-14
EP1350854A1 (de) 2003-10-08
EP0922114A2 (de) 1999-06-16
JP2000517181A (ja) 2000-12-26
AU3862097A (en) 1998-03-19
ATE323180T1 (de) 2006-04-15
EP0922114B1 (de) 2003-10-29
DE69735684T2 (de) 2007-04-05
DE69725861D1 (de) 2003-12-04
CN1232509A (zh) 1999-10-20
WO1998008974A2 (en) 1998-03-05
CA2264246A1 (en) 1998-03-05
NZ334492A (en) 2000-09-29
ATE253128T1 (de) 2003-11-15
AU717736B2 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
DE69735684D1 (de) Katalytische Nukleinsäure und deren medizinische Verwendung
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
DK1100880T3 (da) Urat oxidase
ES2085245T3 (es) Procedimiento de purificacion de acidos nucleicos.
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
NO990025D0 (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
ATE377072T1 (de) Neues gen für eine aminosäure-deacetylase mit spezifität für n-acetyl-l-phosphinothricin, ihre isolierung und verwendung
PT87083A (pt) Vascular-antikoaquilierende proteine dna die diese kodieren verfahren zu deren herstellung sowie deren verwendung
ATE342911T1 (de) Synthese von nukleosiden und polynukleotiden
DE59306681D1 (de) Neue ketoester-reduktase, deren herstellung und verwendung für enzymatische redoxreaktionen
DE60036297D1 (de) Bedingtes 'gene trapping'-konstrukt zur unterbrechung von genen
ATE374034T1 (de) Konditioniertes medium und diffusionsfähiges biologisches material gewonnen durch inkubierung von eingeschlossenen zellen
JPS6430588A (en) Foreign dna developing promoter n methylotroph bacteria, its production and use
ES2085403T3 (es) Gen de origen microbiano para peroxidasa.
DE69809930T2 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ATE528392T1 (de) Neues protein und dessen dns
ATE309371T1 (de) Protein mit dnase-aktivität
MX9709596A (es) Adn catal ??tico.
Meyer The lure of biotech stocks.
ATE49964T1 (de) Benzodioxepane, verfahren zur herstellung und verwendung als heilmittel.
TW276191B (en) Catalyst for production of acrylic acid and method for production of acrylic acid by the use of the catalyst

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee